Utility of histiocytic immunomarkers in differentiating histiocytic aggregates with marked nuclear atypia from high grade squamous intraepithelial lesions in liquid-based cervicovaginal cytology specimens.
Giorgadze
Tamar
T
Miller
Lou Ellen
LE
Preiszner
Johanna
J
Nassar
Aziza
A
D000328:Adult; D000911:Antibodies, Monoclonal / Q000032:analysis*; D015703:Antigens, CD / Q000032:analysis*; D015214:Antigens, Differentiation, Myelomonocytic / Q000032:analysis*; D015415:Biomarkers / Q000032:analysis*; D002467:Cell Nucleus / Q000648:ultrastructure; D002584:Cervix Uteri / Q000473:pathology*; D005260:Female; D006644:Histiocytes / Q000737:chemistry* / Q000473:pathology / Q000648:ultrastructure; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D014621:Vagina / Q000473:pathology*; D014626:Vaginal Smears / Q000379:methods; D000097382:CD68 Molecule
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D015415:Biomarkers; C067980:CD68 antigen, human; D000097382:CD68 Molecule; C096893:HAM-56 antibody